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ABSTRACT 
Introduction: Effective diabetes pharmacotherapy often involves injectable medications, which if used inappropriately represents a 
type of unintentional medication nonadherence that leads to poor outcomes.   
Objectives: The primary objective of this study was to assess the percent of patients who accurately prepared, administered, stored, 
and disposed of their injectable diabetes medication. Secondary objectives included comparing the accuracy of injectable use among 
those with diabetes <5 years vs. ≥ 5 years duration and those with limited vs. proficient health literacy.  
Methods: This was a prospective analysis conducted on a convenience sample of patients who received a pilot pharmacist-led, quality 
improvement service at an urban, ambulatory care clinic.  The service components included health literacy screening, using the Rapid 
Assessment of Adult Literacy in Medicine – Short Form (REALM-SF) tool, evaluation of injectable technique by use of a standardized 
questionnaire, and provision of medication education. Duration of diabetes was determined by patient self-report.  Chi-square and 
Fisher’s exact tests were utilized to assess accuracy of injectable technique in two group comparisons: (1) patients with lim ited vs. 
proficient health literacy and (2) patients with diabetes <5 years vs. ≥5 years.  
Results: Thirty-five patients were included in the analysis. Despite the majority (71.4%) of patients reporting prior education on 
injectable use, 54.3% reported at least one error in product use.  Significant findings noted were that those with limited health literacy 
had higher rates of accurately using the skin-fold technique and appropriate angle for injection vs. those with proficient health literacy 
(p<0.05 for both comparisons). Likewise, more patients in the cohort of diabetes duration ≥5 years accurately rotated the injection site 
vs. those with a duration <5 years (p=0.001).   
Conclusion: Errors in injectable technique were common in this study and spanned across health literacy levels and duration of diabetes. 
Patients prescribed injectable diabetes medications should be routinely educated on proper technique for use.     
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INTRODUCTION 
Appropriate therapeutic management of diabetes often 
involves the use of multiple pharmacotherapies and routinely 
relies on non-oral routes for medication delivery. Patients with 
type 1 diabetes are insulin-dependent; oftentimes, patients 
with poorly controlled type 2 diabetes will require the use of 
injectable diabetes medication (i.e., glucagon-like peptide-1 
[GLP-1] agonists and insulin). Correct storage, preparation for 
injection, and injection technique of diabetes medications is a 
critical component of management, as incorrect use can lead to 
variability in glycemic levels and inability to achieve glycated 
hemoglobin A1C goals. Additionally, inappropriate use of 
injectable diabetes medications may cause untoward effects 
such as unexplained hypoglycemia and lipohypertrophy.1 Over 
the past two decades, patients with diabetes have gained 
expanded options for injectable medications beyond the  
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traditional vial and syringe administration of insulin. As medical 
device technology has advanced, various pen devices for insulin 
and other injectable diabetes therapies have been developed 
and have increased the likelihood for more accurate dosing and 
less painful administration.2 These devices are being 
increasingly prescribed and utilized by patients due to 
purported ease of use and convenience.3,4 Correct 
administration of injectable medications for diabetes 
management is crucial to controlling hyperglycemia, and 
inappropriate use of these agents represents a type of 
medication nonadherence that may result in poor health 
outcomes.5   
Medication nonadherence can be classified into two main 
types, intentional and unintentional nonadherence.6  
Intentional nonadherence occurs when a patient willfully 
decides not to follow medication recommendations - typically 
due to factors related to a patient’s belief system, such as fear 
of adverse effects, stigma, or medication beliefs.6,7 
Unintentional nonadherence occurs primarily due to a patient’s 
lack of capacity or resources to appropriately take a medication 
as recommended.6,7 This type of nonadherence may be caused 
by forgetfulness, cognitive impairment, inability to understand 
device-use instructions, and difficulty with medication 
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administration as a result of limited health literacy (HL).6,7  
Although inappropriate use of injectables can represent a type 
of unintentional nonadherence, the exact impact of limited HL 
on this type and intentional medication nonadherence in 
diabetes has not been clearly defined in the literature.8  
 
Limited HL is not only associated with poor medication 
adherence but has also been linked with poor clinical outcomes 
in various conditions, including diabetes.9 Studies  evaluating 
the  association of HL with health outcomes and disease state 
self-management knowledge in patients with diabetes, provide 
variable insights. Sayah et al. evaluated the associations 
between HL and health outcomes in a predominantly low-
income patient population with type 2 diabetes and found that 
inadequate HL was significantly correlated with diabetes 
knowledge; however, no differences in cardiometabolic 
outcomes were observed.10 In another study, Piatt et al. found 
that insulin-taking diabetes patients with a high likelihood of 
limited functional health literacy (FHL) were six times more 
likely to have uncontrolled blood glucose levels (A1C ≥8.0%, ≥64 
mmol/mol) compared to those with possible limited FHL or 
adequate FHL.11  Whereas, a systematic review conducted by 
Sayah et al. reported an overall discrepancy in evidence on the 
relationship with HL or numeracy skills and numerous health 
outcomes (e.g. glycemic control, self-care behaviors, and 
diabetes complications) in patients with diabetes.12 The lack of 
clear consensus on the contribution of HL on factors which 
impact the therapeutic management of diabetes suggests a 
need for further study.  
 
The purpose of this analysis was to assess the relationship 
between self-reported accuracy in injectable technique – 
defined in this study as storage, preparation, administration, 
and disposal of the medication(s) – and patients’ health literacy 
level and duration of diabetes. The investigators sought to 
examine whether limited vs. proficient HL and short vs. long 
duration of diabetes would be related to rates of accuracy in 
injectable use. This data would be useful to inform the 
development of tailored educational interventions that reduce 
the occurrence of unintentional nonadherence to antidiabetic 
injectables.  
 
METHODS 
Study Sample and Setting  
This was a prospective analysis conducted on a convenience 
sample of patients who received a pilot pharmacist-led, quality 
improvement service within the diabetes clinic at an urban, 
ambulatory care clinic in Birmingham, Alabama. Alabama 
currently holds the second highest ranking among the country 
in diabetes prevalence, with 14.6% of adults in Alabama in 2017 
reported being told by a health professional that they have 
diabetes compared to the national average of 10.5%.13,14 The 
clinic in this study is a county-operated, outpatient healthcare 
center located within the metropolitan Birmingham area that 
provides ambulatory care services for residents via a subsidized 
care model.15 The clinic primarily serves financially 
disadvantaged patients who are routinely impacted by resource 
limitations that negatively affect their health (e.g., limited HL, 
poor medication adherence, limited disease self-management 
skills).  
 
In February of 2018, the area school of pharmacy collaborated 
with the practice to implement clinical pharmacy services 
within the diabetes clinic. The pharmacy service was 
implemented in the clinic at no cost to patients and was 
designed as a quality improvement program focused on 
improving the medication use process. Non-pregnant, English-
speaking, adult patients with a documented diagnosis of type 1 
or type 2 diabetes received the quality improvement service, if 
they were a patient of the diabetes clinic and were prescribed 
an injectable diabetes medication. The faculty affiliate clinical 
pharmacist and fourth year pharmacy students on rotation 
were the pharmacy personnel who staffed the service. 
 
A standard component of the pharmacy service was that all 
patients received the pharmacy Pre-Visit. The following patient 
care services were provided and documented during the Pre-
Visit: HL screening utilizing the validated Rapid Assessment of 
Adult Literacy in Medicine—Short Form (REALM-SF) tool16; 
medication adherence screening utilizing open-ended 
questions modified from items on the Drug Adherence Work-
up (DRAW) tool; medication reconciliation of prescription and 
non-prescription products; identification of medication-related 
problems including drug interactions, side effects, and 
opportunities for dose optimization; assessment of injection 
technique, storage, and preparation for prescribed injectable 
diabetes agents utilizing a standardized questionnaire 
(Appendix 1); and provision of medication education.  
 
The 7-item REALM-SF tool is a validated tool that uses word 
recognition of medical terms for a quick assessment of health 
literacy and takes less than two minutes to administer.16  The 
REALM-SF tool is administered as the standard of care for 
pharmacy HL screenings within the clinic of this study. Although 
the REALM-SF does not assess numeracy and prose similar to 
other tools (e.g. Newest Vital Sign, Test of Functional Health 
Literacy Assessment, and Diabetes Numeracy Test), it was 
utilized in this pharmacy intervention as a practical method for 
identification of limited HL within the time constraints of real-
world clinic encounters.  
 
Injectable technique - including preparation, administration, 
disposal and storage of the medication - was evaluated by use 
of a standard questionnaire to elicit a description of each step.  
 
Two pharmacy personnel served as raters and were trained to 
evaluate patients’ responses to the questionnaire items and 
provided a subsequent assessment on appropriate use, based 
upon the package insert of the medication.  Prior to each Pre-
Visit encounter, raters conducted a chart review of patients 
scheduled in clinic in order to ensure raters were 
knowledgeable of the labeled device use instructions. The two 
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raters interviewed patients together to gather responses to the 
questionnaire. There were no cases of disagreement among the 
raters; however, a third rater was available for cases of 
disagreement. Whenever errors in any step of injectable 
technique were noted, the patient was educated on 
appropriate use and technique utilizing verbal instruction along 
with patient education handouts and the teach-back method to 
ensure comprehension.17,18  
 
Study Objectives  
The primary objective of this study was to assess the percent of 
patients in the study population who properly prepared, 
administered, stored, and disposed of their injectable diabetes 
medication. Secondary objectives included comparing the 
percent of patients with proper injection technique among two 
groups: those with diabetes duration of <5 years vs. diabetes 
duration ≥ 5 years and those with limited HL (in this study, 
defined as REALM-SF score ≤3) vs. proficient HL (defined in this 
study as REALM-SF >3).  
 
A REALM-SF score of ≤3 was characterized as limited HL in this 
study and was reported as a composite score of patients who 
received either a score of 0 – defined as third grade and below; 
will not be able to read most low-literacy materials – or a score 
of 1-3 – defined as fourth to sixth grade; will need low-literacy 
materials, may not be able to read prescription labels.16 
 
Short duration of diabetes was defined as <5 years in this study 
and was based on the following: (a) internal data of the average 
patient age in the practice of 50 years; (b) predominance of 
type 2 DM at the clinic; (c) CDC data on type 2 DM prevalence 
at ≥ 45 years of age; (d) and the recommendation from the 
American Diabetes Association and Academy of Nutrition and 
Dietetics that the initial referral to diabetes education be made 
at diagnosis.19,20  Given CDC data on type 2 DM prevalence 
being dramatically increased after age 45 and the average age 
of the clinic’s patient population, investigators selected 5 years 
as the cut-off for short duration and >5 for long duration.  The 
authors presumed that, as with evidence on inhaler technique, 
educational interventions on injectable technique would be 
most effective in the short-term.21 Presuming those with 
diabetes of a shorter duration would have been educated more 
recently than those of a longer duration, the study sought to 
evaluate if duration is associated with accuracy of technique.  
 
Statistical Analyses  
Statistical analyses were conducted using SPSS 25.0 (Released 
2017 IBM SPSS Statistics for Windows, Version 25.0. Armonk, 
NY: IBM Corp). Chi-square tests were utilized to analyze 
associations between limited and proficient HL levels and the 
categorical responses of yes or no to items related to the 
patient’s accuracy in preparation, administration, disposal, and 
storage of injectable agents. For cases where a cell had n<5, the 
Fisher’s Exact test was utilized. The associations between 
accuracy of injectable use and diabetes duration, categorized as 
<5 years and ≥5 years, were analyzed with the same statistical 
technique. An alpha value of p<0.05 was considered statistically 
significant. This study was reviewed and approved by the 
Samford University Institutional Review Board and a waiver of 
consent was granted.  
 
RESULTS 
Patient Population  
Patient demographics are provided in Table 1. A total of 35 
patients were included in the analysis. The mean (SD) age of the 
population was 56.1 (11.9) years, and the majority of patients 
identified as female and were African American. Thirty-two 
patients in the study had a documented A1C within 4 months 
of the date of the Pre-Visit intervention. All 32 of those patients 
with a documented A1C were noted with an A1C > 7.0% (>53 
mmol/mol), which is above the general goal for non-pregnant 
adults based upon the 2019 American Diabetes Association 
(ADA) Standards of Medical Care in Diabetes guidelines.22 The 
majority (71.4%) of patients reported receiving education on 
their injectable medication prior to the pharmacy intervention. 
Prior education was defined as attending at least one Diabetes 
Self-Management Education (DSME) class offered at the clinic 
or another medical practice or pharmacy. 
 
Assessment of injectable technique  
Table 2 provides data on patients whose affirmative responses 
during the pharmacy intervention suggested that they 
appropriately prepare, administer, dispose and store their 
injectable diabetes medications. Nineteen of the 35 patients 
(54.2%) included in this study described inappropriate use of 
their injectable in at least one step - preparation, storage, 
administration, or disposal. In regard to preparation technique, 
the majority of patients reported properly washing their hands 
prior to injection and cleaning the injection site (62.9% and 
85.7%, respectively), while less than half (45.7%) of patients 
described properly preparing the injectable medication for use.  
The majority (97.1%) of patients reported administering at an 
appropriate injection site, but one patient reported improper 
administration in the shoulder area, above the clavicle. 
Approximately half (51.4%) of patients reported using the 
proper skin-fold technique for administration, and the majority 
(62.9%) of patients described administration of the injectable 
at a 90-degree angle. Likewise, the majority of patients 
reported proper disposal of sharps (i.e., needles, syringes, and 
lancets) and appropriate storage of their injectable (68.8% and 
94.3%, respectively). 
 
Association between HL level and injectable technique 
The analysis of the association between HL level and injectable 
technique is provided in Table 3. A REALM-SF score was 
documented in the medical record for 25 patients in the sample 
– five of which were characterized as having limited HL and 20 
with proficient HL. The majority of patients in both HL groups 
reported proper handwashing, cleaning of the injection site, 
selection of the appropriate injection site, rotation of injection 
site, proper disposal of sharps, and proper storage of the 
injectable medication. Noted differences between HL levels 
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were found in appropriate preparation of the injectable for use, 
injecting at a 90-degree angle, use of proper skin-fold 
technique, and appropriate needle placement time. The 
majority (60.0%) of patients in the limited HL group reported 
proper preparation of the injectable for use compared with 
35.0% of patients in the proficient HL group. Additionally, the 
majority (80.0%) of patients in the limited HL group reported 
appropriate needle placement time vs. 35.0% in the proficient 
HL group. A significant difference among HL groups was noted 
with appropriate skin-fold technique and 90-degree angle for 
injection, where all patients in the limited HL group reported 
appropriate administration technique vs. <50% of patients in 
the proficient HL group (p=0.015 and 0.046, respectively).  
 
Association between duration of diabetes and injectable 
technique 
Table 4 provides the evaluation of the association between 
duration of diabetes and injectable technique. Four patients in 
the study were characterized as having diabetes of a short 
duration, and the remaining 29 patients had diabetes of long 
duration. The majority of patients in both groups reported 
appropriate handwashing, cleaning of the injection site, 
selection of the appropriate injection site, and proper storage 
of the injectable medication. Differences between groups were 
noted in use of a 90-degree angle for injection, rotation of the 
injection site, and proper disposal of sharps.  The majority 
(69.0%) of patients with diabetes of long duration reported 
rotating the injection sites and proper disposal of sharps vs. 
25.0% of those with diabetes of short duration (p=0.216 for 
both comparisons). Similarly, the majority (93.1%) of patients 
with diabetes of long duration reported appropriate rotation of 
the injection site vs. 25.0% of patients with diabetes of short 
duration (p=0.001).  
 
DISCUSSION  
To our knowledge, this is the first study to evaluate use of 
antidiabetic injectables, to include insulin products and GLP-1 
agonists, and that defined product use in its entirety of 
preparation, administration, disposal, and storage. 
Additionally, to our knowledge it is the first to assess the 
relationship between accuracy of injectable use and HL level 
and duration of diabetes. Our results showed that despite the 
majority of patients receiving prior education on appropriate 
injectable technique, over half of patients made errors in either 
the storage, preparation, administration, or disposal of the 
injectable medication. This is consistent with other discrete 
study findings in patients with diabetes taking an insulin 
product.23-25  
 
The most common error in injectable technique noted in this 
analysis was inappropriate preparation of the injectable for use. 
There is a dearth of published literature evaluating preparation 
of injectable medications for use, with the available evidence 
evaluating reconstitution of NPH insulin.23 In the Worldwide 
Injection Technique study, 65.5% of patients were prescribed 
NPH, and 85.4% of those patients reported rolling the vial at 
least twice, for reconstitution, prior to administration.23 In our 
study, more than half of patients inappropriately prepared the 
injectable for use by neglecting to either mix to warm or 
reconstitute per package instructions, inspect for particles, or 
prime at first use when indicated.  
 
Errors noted in more than one-third of patients in our study 
were neglecting to use the skin-fold technique or 90-degree 
angle for injection, inappropriate needle placement time, and 
improper handwashing. Published literature on skin-fold 
technique and handwashing is consistent with our findings. A 
study by Hirsch et al. reported on the results of the Worldwide 
Injection Technique Questionnaire Study and found that only 
48.0% of patients appropriately pinched the skin and removed 
the needle prior to release in the skin-fold technique.25 
Regarding hand hygiene, a study by Vianna et. al – evaluating 
an elderly population >70 years of age – found that 87.2% of 
patients inappropriately washed their hands.26 Studies 
evaluating injection with 90-degree angle and needle 
placement time has conflicting findings. In the Vianna et al. 
study, 100% of patients appropriately used a 90-degree angle 
for insulin injection.26  Whereas, a study by Partanen et. al. 
found that 50% of patients injected with a 90-degree angle – 
which is consistent with our study findings.27 Similar to our 
results on needle placement time, Mitchell et al. found that up 
to 50% of patients failed to keep the pen needle under the skin 
for the appropriate time as directed by the manufacturer.28 
However, Zhao et al. reported 99.4% of patients kept the pen 
needle under the skin for greater than 10 seconds, which was 
appropriate for the injectables studied.29 
 
In our study, errors in injectable technique were noted to occur 
across HL levels and in patients with diabetes of a varying 
duration. There were no statistically significant differences 
among HL groups and duration of diabetes in committing the 
most commonly noted error in this study - inappropriate 
preparation of the injectable for use. However, differences in 
accuracy among the HL levels and diabetes duration subgroups 
were noted in skin-fold technique, injection at 90-degree angle, 
and rotation of injection site. In our analysis, a statistically 
significant difference was noted among HL levels in the errors 
of neglecting to use of skin-fold technique and 90-degree angle 
for injection - with these errors committed more in the 
proficient HL group versus the limited HL group. It would be 
assumed that more patients with a higher proficiency of HL 
would report appropriate injectable use in comparison to those 
with limited HL. However, contradictory results were found in 
our study – with 35.0% and 45.0% of patients with proficient HL 
reporting appropriate use of the skin-fold technique and 
injection at a 90-degree angle, respectively, compared to 100% 
of the patients with limited HL at both data points (p=0.015 and 
0.046). There were no appreciable themes in data to formulate 
a meaningful speculation on the reasoning behind these 
findings.  
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There are limited studies that discriminate between intentional 
and unintentional nonadherence in diabetes, and to our 
knowledge, no studies that further classify the types of 
unintentional nonadherence (e.g. forgetfulness vs. 
inappropriate injectable technique). The few studies evaluating 
the relationship between HL and unintentional nonadherence 
have conflicting results.  Fan et al. conducted an analysis in a 
medically underserved patient population with diabetes and 
found that patients with limited HL were more likely to be  
unintentionally nonadherent (OR=1.87, p=0.048).30  However 
Sayah et al. found no significant correlation between HL level 
and medication adherence in a predominately African 
American community with type 2 diabetes (r=0.025; p=0.784).10 
Thus, the relationship between HL level and inappropriate 
medication or device use as a type unintentional nonadherence 
remains unclear.  
 
Duration of diabetes was associated with a significant 
difference in rotating the injection site in our study – with those 
who had diabetes of short duration (<5 years) committing more 
errors than those with diabetes of long duration (p=0.001). 
Available literature on injectable technique, has not evaluated 
the relationship between the duration of diabetes and 
appropriateness of technique. However, the finding that 
patients routinely fail to rotate the injection site is an error 
commonly noted in the literature – with reported prevalence of 
this error ranging from 16-70%.23,26,27,31   
 
Injectable diabetes medications may be difficult to use if 
patients are not appropriately educated regarding use. In July 
2018, the U.S. Food and Drug Administration (FDA) reported 
the addition of thirteen insulin pen products to its watch list due 
to failure to remove the inner needle cover prior to 
administration.32 While not included in the FDA update, it can 
be assumed that the warning regarding the removal of an inner 
needle cover could be extrapolated to the GLP-1 agonists which 
utilize a similar system for administration (i.e., Byetta®, 
Bydureon®, Victoza®, Adylyxin®, and Ozempic®).33-37 Although 
this particular step was not evaluated in our study design, the 
FDA warning further highlights the need to routinely evaluate 
and educate on appropriate injectable technique in diabetes.  
 
Practitioners should ensure instruction on injectable technique 
is incorporated within educational interventions in order to 
ensure optimal compliance with the National Standards of 
Diabetes Self-Management Education and Support curriculum 
core topic - using medication(s) safely and for maximum 
therapeutic effectiveness.38 Delivery models of DSME have 
evolved over the years to incorporate patient empowerment 
vs. traditional didactic presentations for education and have 
demonstrated positive results of improved self-efficacy and 
glycemic control in patients with DM.39,40 Additionally, evidence 
suggests that patients and caregivers most often rank live 
demonstration with the teach-back method above other 
methods of patient education (e.g. verbal instruction, written 
directions, video instruction); it is well-documented in the 
literature that patients utilize medicine devices (i.e., inhalers) 
more appropriately when provided opportunities to learn by 
demonstration.41-43 Therefore, it can be speculated that 
incorporation of training aids and live demonstration strategies 
into DSME education, while utilizing an empowerment model 
of delivery, would be an effective strategy for initial educational 
efforts in DM as well as for remediation in follow up contact 
with patients. 
 
This study has important limitations. It was a prospective study 
utilizing a small sample from a single outpatient facility, which 
may limit external validity. Lack of documented REALM-SF 
results in ten patients further limited the sample size for 
evaluation of the relationship between HL level and injectable 
technique. Furthermore, in the comparisons of the association 
between HL or duration of diabetes and injectable technique, 
both the limited HL group and the diabetes of short duration 
group had ≤5 subjects. Additionally, duration of diabetes and 
HL were independently assessed variables in this study and 
were not examined as covariates to measure their influence on 
injectable technique, which suggests a potential area for future 
study. Another notable limitation is that the evaluation of 
injectable technique was based on patient self-report 
responses to a questionnaire versus observation, which may 
have led to an overestimation of appropriate use. Discordance 
between self-report and observation of injectable technique 
has been documented in the literature and should be taken into 
consideration for future evaluations.23  Lastly, in general the 
questionnaire utilized plain language, open-ended items to 
elicit patient responses in accordance with Health Literacy 
Universal Precautions Toolkit.44  It should be noted that some 
close-ended items were included in the questionnaire to 
further elicit the intent of associated open-ended items, and 
thus may have influenced patient responses toward an 
affirmative answer. However to minimize such response bias, 
the questionnaire included numbered elements with each 
scripted item that directed raters to assess a patient’s 
descriptive answer when assigning an affirmative or negative 
response related to injectable technique vs. solely recording a 
patient’s “yes” or “no” answer to a close-ended item. 
 
CONCLUSION  
More than half of patients in this study had a noted error in the 
use of their injectable diabetes medication. The most common 
errors noted were inappropriate preparation of the injectable 
for use; inconsistent use of the skin-fold technique to improve 
injection accuracy and comfort; and inconsistency in keeping 
the needle under the skin, per labeled instructions. Appropriate 
injectable technique is critical to achieving therapeutic goals for 
many patients with diabetes. Therefore, it is recommended 
that clinicians routinely evaluate and educate on appropriate 
technique for patients receiving injectable diabetes 
medications (i.e., reviewing the steps of preparation, 
administration, storage, and disposal). These educational 
interventions should not be limited to patients with limited HL 
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or diabetes of short duration, as errors in technique were 
prevalent among all groups.  
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Table 1. 
Patient Demographics 
  
Characteristics (N = 35) n %a 
   
Race 
African American 
Caucasian 
 
29 
6 
 
82.9 
17.1 
Health Insurance 
Insured 
Uninsured 
 
21 
14 
 
60 
40 
Diabetes Diagnosis 
Type 1 
Type 2 
 
3 
32 
 
8.6 
91.4 
Prescribed injectables (N=44)  n %b 
     Basal insulin via vial/syringe                                                          14                     31.8 
     Bolus insulin via vial/syringe                                                          4                        9.1                                                                 
     Basal insulin via pen device                                                            13                   29.5                                       
     Bolus insulin via pen device                                                            3                       6.8                                                     
     Pre-mixed insulin via vial/syringe                                                  8                     18.2                                                    
     GLP-1 agonist via pen device                                                          2                       4.6                        
apercentage for N=35; bpercentage for N=44 
 
 
 
Table 2. 
Assessment of Preparation, Administration, Disposal, and Storage of Injectable Diabetes Medication: 
Summary for all patients  (N = 35) 
Appropriateness of Technique 
Yes 
No. (%) 
No 
No. (%) 
Preparation 
Proper hand washing 
Cleans injection site 
Appropriately prepares injectable for use 
 
22 (62.9) 
30 (85.7) 
16 (45.7) 
 
13 (37.1) 
5 (14.3) 
19 (54.3) 
 
Administration and Disposal 
Appropriate injection site 
Use of skin-fold technique 
Use of 90-degree angle 
Rotates injection site 
Appropriate needle placement time 
Proper disposal of sharps (needles, syringes, and lancets) 
 
34 (97.1) 
18 (51.4) 
22 (62.9) 
30 (85.7) 
19 (54.3) 
24 (68.6) 
 
1 (2.9) 
17 (48.6) 
13 (37.1) 
5 (14.3) 
16 (45.7) 
11 (31.4) 
Storage 
Proper Storage 
 
33 (94.3) 
 
2 (5.71) 
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Table 3. 
Assessment of Preparation, Administration, Disposal, and Storage of Injectable Diabetes Medication: 
Limited HL † vs. Proficient HL † 
Appropriateness of Technique 
REALM-SF Score ≤3 
(n=5), No. ‡ (%) 
REALM-SF 
Score >3 
(n=20), No. ‡ (%) 
P-value 
Preparation 
Proper hand washing 
Cleans injection site 
Appropriately prepares injectable for use 
 
4 (80.0) 
4 (80.0) 
3 (60.0) 
 
19 (95.0) 
16 (80.0) 
7 (35.0) 
 
0.322 
       1 
0.358 
Administration and Disposal 
Appropriate injection site 
Use of skin-fold technique 
Use of 90-degree angle 
Rotates injection site 
Appropriate needle placement time 
Proper disposal of sharps (needles, syringes, 
and lancets) 
 
5 (100) 
5 (100) 
5 (100) 
5 (100) 
4 (80.0) 
3 (60.0) 
 
19 (95.0) 
7 (35.0) 
9 (45.0) 
16 (80.0) 
7 (35.0) 
12 (60.0) 
 
       1 
0.015 
0.046 
0.549 
0.133 
       1 
Storage 
Proper Storage 
 
4 (80.0) 
 
19 (95.0) 
 
0.367 
† HL = health literacy 
‡ Number of yes responses to standardized questionnaire on appropriate use 
 
 
 
 
 
 
Table 4. 
Assessment of Preparation, Administration, Disposal, and Storage of Injectable Diabetes 
Medication: Diabetes of Short Duration vs. Diabetes of Long Duration 
Appropriateness of Technique 
DM† duration  
<5 yrs.  
(n=4), No. ‡ (%) 
DM† duration  
≥5 yrs. 
(n=29), No. ‡ (%) 
P-value 
Preparation 
Proper hand washing 
Cleans injection site 
Appropriately prepares injectable 
for use 
 
3 (75.0) 
4 (100) 
1 (25.0) 
 
18 (62.1) 
24 (82.8) 
14 (48.3) 
 
0.818 
0.547 
0.676 
Administration and Disposal 
Appropriate injection site 
Use of skin-fold technique 
Use of 90-degree angle 
Rotates injection site 
Appropriate needle placement 
time 
Proper disposal of sharps 
(needles, syringes, and lancets) 
 
4 (100) 
2 (50.0) 
1 (25.0) 
1 (25.0) 
2 (50.0) 
1 (25.0) 
 
28 (96.6) 
15 (51.7) 
20 (69.0) 
27 (93.1) 
16 (55.2) 
20 (69.0) 
 
0.899 
0.997 
0.216 
0.001 
0.974 
0.216 
Storage 
Proper Storage 
 
4 (100) 
 
26 (90) 
 
0.399 
† DM= diabetes mellitus 
‡Number of yes responses to standardized questionnaire on appropriate use 
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Appendix 1. Standardized Questionnaire: 
Preparation, Administration, Disposal, and Storage of Injectable Diabetes Medication 
 
Script: “Please describe how you prepare to give your ____ [insert name of injectable diabetes medication(s)]. Do you wash 
your hands before the injection? If yes, describe how you wash your hands.”  
1. Does the patient describe proper handwashing technique? Yes/No 
Script: “Do you clean the area where you will inject? If yes, describe how you clean the area.” 
2. Does the patient describe proper cleaning of the injection site? Yes/No 
Script: “How do you prepare the actual injection before use? Describe how you mix/prime/warm the injection.”  
3. Does the patient describe the appropriate method of preparing the injectable for use? Yes/No 
Script: “Please describe how you administer or inject ____ [insert name of injectable diabetes medication(s)].” 
4. Does the patient describe injecting in the appropriate site? Yes/No 
5. Does the patient describe using the skin-fold technique? Yes/No 
6. Does the patient describe injecting at a 90-degree angle? Yes/No 
Script: “Do you inject in the same place each time or rotate sites?” 
7. Does the patient describe rotating the injection site? Yes/No 
Script: “How long to you leave the needle under the skin when you are giving yourself the injection?” 
8. Does the patient describe appropriate needle placement time with the injection? Yes/No 
Script: “Please describe how you dispose of ____ [insert name of injectable diabetes medication(s)]. Where do you dispose 
of used pens/needles/syringes?” 
9. Does the patient dispose of the injectable appropriately? Yes/No 
Script: “Please describe how you store ____ [insert name of injectable diabetes medication(s)] until it’s time to use the 
medication.” 
10. Does the patient describe storing the injectable appropriately per the product labeling? Yes/No 
 
